Publisher Correction: Fibrosis: cross-organ biology and pathways to development of innovative drugs
- DOI
- 10.1038/s41573-025-01190-9
- Published
- 2025-03-31
- Container
- Nature Reviews Drug Discovery
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1038/s41573-025-01190-9,
title = {Publisher Correction: Fibrosis: cross-organ biology and pathways to development of innovative drugs},
author = {Florian Rieder and Laura E. Nagy and Toby M. Maher and Jörg H. W. Distler and Rafael Kramann and Boris Hinz and Marco Prunotto},
year = {2025},
journal = {Nature Reviews Drug Discovery},
doi = {10.1038/s41573-025-01190-9},
url = {https://doi.org/10.1038/s41573-025-01190-9}
}RIS
TY - JOUR TI - Publisher Correction: Fibrosis: cross-organ biology and pathways to development of innovative drugs AU - Florian Rieder AU - Laura E. Nagy AU - Toby M. Maher AU - Jörg H. W. Distler AU - Rafael Kramann AU - Boris Hinz AU - Marco Prunotto PY - 2025 JO - Nature Reviews Drug Discovery DO - 10.1038/s41573-025-01190-9 UR - https://doi.org/10.1038/s41573-025-01190-9 ER -
APA
Rieder, F., Nagy, L. E., Maher, T. M., Distler, J. H. W., Kramann, R., Hinz, B., & Prunotto, M. (2025). Publisher Correction: Fibrosis: cross-organ biology and pathways to development of innovative drugs. Nature Reviews Drug Discovery. https://doi.org/10.1038/s41573-025-01190-9
Source records
- crossref · retrieved 2026-09-26T06:49:26.723Z